| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2014-07-22 | octreotide acetate | preclinical | Glide Pharma (UK) | ||
| 2014-07-21 | MM-D37K | advanced solid malignancies, including glioblastoma and gastrointestinal tumors |
1-2a | Metamax (Russia) | Cancer - Oncology |
| 2014-07-18 | Eylea® (VEGF Trap-Eye - aflibercept ophthalmic solution) | diabete macular edema (DME) |
3 | Bayer Healthcare (Germany) Regeneron Pharmaceuticals (USA) | Ophtalmological diseases |
| 2014-07-17 | ISIS-APO(a) Rx | high lipoprotein(a), or Lp(a) |
2 | Isis Pharmaceuticals (USA - CA) | Cardiovascular diseases - Metabolic diseases |
| 2014-07-17 | Eliquis® (apixaban) | anticoagulant use in patients with nonvalvular atrial fibrillation (NVAF) undergoing cardioversion |
4 | BMS (USA - NY) Pfizer (USA - NY) | Cardiovascular diseases |
| 2014-07-17 | Vyvanse® (lisdexamfetamine dimesylate) | Attention-Deficit Hyperactivity Disorder (ADHD) |
4 | Shire (UK-USA) | CNS diseases - Mental diseases |
| 2014-07-17 | physiocrines | aTyr (USA - CA) The Hong Kong University of Science and Technology (China) The Scripps Research Institute (USA - CA) Stanford University (USA - CA) | Rare diseases | ||
| 2014-07-17 | AMG 416 | secondary hyperparathyroidism in patients with chronic kidney disease |
3 | Amgen (USA - CA) | Hormonal diseases - Endocrine diseases - Renal diseases - Kidney diseases |
| 2014-07-16 | BeneFIX® (recombinant coagulation factor IX product) | moderately severe to severe hemophilia B |
3 | Pfizer (USA - NY) | Genetic diseases - Hematological diseases - Rare diseases |
| 2014-07-16 | Somatuline® Autogel® (lanreotide) 120mg | gastrointestinal and pancreatic neuroendocrine tumors (GEP-NETs) |
3 | Ipsen (France) | Cancer - Oncology |
| 2014-07-16 | inecalcitol | chronic lymphocytic leukemia (CLL) |
2 | Hybrigenics (France) | Cancer - Oncology |
| 2014-07-15 | LMTX™ (leuco-methylthioninium) | Alzheimer\'s disease |
3 | TauRx Therapeutics (Singapore - UK) | Neurodegenerative diseases |
| 2014-07-14 | physiocrines | idiopathic inflammatory myopathies (IIM) dermatomyositis |
aTyr Pharma (USA - CA) | Rare diseases - Autoimmune diseases - Neuromuscular diseases | |
| 2014-07-10 | ADX71441 | nicotine addiction |
preclinical | Addex Therapeutics (Switzerland) | CNS diseases |
| 2014-07-10 | oral fixed-dose combination capsule of netupitant 300 mg + palonosetron 0.50 mg (NEPA) | prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV) following both highly and moderately emetogenic chemotherapy |
2-3 | Helsinn (Switzerland) Eisai (Japan) | Cancer - Oncology |
| 2014-07-09 | dupilumab | moderate-to-severe atopic dermatitis | 2b | Sanofi (France) Regeneron Pharmaceuticals (USA) | Dermatological diseases - Immunological diseases - Inflammatory diseases |
| 2014-07-09 | XEN-D0501 | chronic idiopathic cough (CIC) |
2a | Ario Pharma (UK) | Respiratory diseases - Inflammatory diseases |
| 2014-07-09 | Otezla® (apremilast) | ankylosing spondylitis |
3 | Celgene (USA - NJ) | Autoimmune diseases – Inflammatory diseases - Rheumatic diseases |
| 2014-07-09 | Elad® (Extracorporeal Liver Assist Device) | alcohol induced liver decompensation acute alcoholic hepatitis |
3 | Vital Therapies (USA - CA) | Hepatic diseases - Liver diseases |
| 2014-07-09 | selective inhibitors of IKK-epsilon and TBK1 | chronic obstructive pulmonary disease (COPD) inflammatory diseases |
preclinical | Domainex (UK) | Inflammatory diseases - Respiratory diseases |
